[Own experiences (1989-1994) in the treatment of adolescent schizophrenic paranoid syndromes with Leponex produced by Sandoz company].
31 patients with schizophrenic adolescent paranoid syndrome were treated by Leponex-Sandoz after the establishing of the therapeutic indications. We did not observe any considerable side effects. We observed the regression of positive symptoms at 19-day of the treatment and the regression of negative symptoms at 23-day of the therapy. We conclude that Leponex-Sandoz is effective and safe medication in the treatment of adolescent schizophrenic paranoid syndrome.
Abczyńska
M
M
Oddziału Psychiatrii Wieku Rozwojowego Wojewódzkiego Szpitala Neuropsychiatrii w Lublińcu.
Kaźmirek
Z
Z
Syguda
J
J
Termińska
K
K
D000293:Adolescent; D003024:Clozapine / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D000297:Psychology, Adolescent; D012563:Schizophrenia, Paranoid / Q000188:drug therapy*; D016896:Treatment Outcome
D003024:Clozapine
Własne piecioletnie doświadczenia (1989-1994) w leczeniu młodziezowych, schizofrenicznych zespołów paranoidalnych Leponexem firmy Sandoz.